DCGI
COVID-19 Vaccine Update: Serum Institute Pauses Coronavirus Vaccine Trails Till Further Orders From DCGI, Say Reports
COVID-19 Vaccine Update: Serum Institute of India Says Will Adhere to DCGI Instructions After Show Cause Notice Over Not Pausing Trial of Covishield Vaccine
COVID-19 Vaccine Update: DCGI Sends Show Cause Notice to Serum Institute of India for Not Pausing Trial of Covishield
COVID-19 Vaccine Update: Serum Institute of India Initiates Phase 2, 3 Clinical Study of 'Covishield' on 1,600 Volunteers
COVID-19 Vaccine Update: DCGI Nod to Serum-Oxford Coronavirus Vaccine for Phase 2, 3 Clinical Trials in India
Serum Institute of India Seeks DCGI Permission for Phase 2/3 Clinical Trials of Oxford's COVID-19 Vaccine
Cipla Gets DCGI Nod to Sell Favipiravir Under Brand 'Ciplenza' to Treat Mild And Moderate COVID-19 Patients
Cipla Gets Regulatory Nod from DCGI for Launch of Ciplenza to Treat Mild to Moderate COVID-19
Cipla Launches Generic Version Of Remdesivir In India, Aims To Supply 80000 Vials Within First Month
Bharat Biotech Vice-President Dr V.K. Srinivas Takes First Shot Of COVID-19 Vaccine? COVAXIN Developer Refutes Claim, Here's a Fact Check
Google Trends